AJP - Endocrinology and Metabolism, Vol 264, Issue 2 E149-E155, Copyright © 1993 by American Physiological Society

ARTICLES

Glucose counterregulation: prevention and correction of hypoglycemia in humans

P. E. Cryer
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

The prevention or correction of hypoglycemia in humans is the result of both dissipation of insulin and activation of glucose counterregulatory (glucose-raising) systems. Whereas insulin is the dominant glucose-lowering factor, there are redundant glucose counterregulatory factors. Furthermore, there is a hierarchy among the glucoregulatory factors. The first defense against a decrement in plasma glucose is decreased insulin secretion; this occurs with glucose decrements within the physiological range at a glycemic threshold of 4.6 +/- 0.2 mmol/l. However, biological glucose recovery from hypoglycemia can occur despite mild (approximately 2-fold) peripheral hyperinsulinemia and can occur in the absence of portal hypoinsulinemia. Thus additional (glucose counterregulatory) factors must be involved. Critical glucose counterregulatory systems are activated at glycemic thresholds of approximately 3.8 mmol/l (the level at which brain glucose uptake is first measurably reduced), well above the thresholds for symptoms of hypoglycemia (approximately 3.0 mmol/l) and those for cognitive dysfunction resulting from neuroglycopenia (approximately 2.7 mmol/l). Among the glucose counterregulatory factors, glucagon plays a primary role. Indeed, it may be that hypoglycemia does not occur if the secretion and actions of both glucagon and insulin, among the glucoregulatory hormones, are normal. Epinephrine is not normally critical, but it becomes critical to glucose counterregulation when glucagon is deficient. Because hypoglycemia develops or progresses when both glucagon and epinephrine are deficient and insulin is present, these three hormones stand high in the hierarchy of redundant glucoregulatory factors.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. C. Ertl, S. Mann, A. Richardson, V. J. Briscoe, H. B. Blair, D. B. Tate, and S. N. Davis Effects of oral carbohydrate on autonomic nervous system counterregulatory responses during hyperinsulinemic hypoglycemia and euglycemia Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E618 - E625. [Abstract] [Full Text] [PDF]

				A Battezzati, P M Battezzati, D Costantini, M Seia, L Zazzeron, M C Russo, V Dacco, S Bertoli, A Crosignani, and C Colombo Spontaneous hypoglycemia in patients with cystic fibrosis Eur. J. Endocrinol., March 1, 2007; 156(3): 369 - 376. [Abstract] [Full Text] [PDF]

				B. Raju and P. E. Cryer Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E181 - E186. [Abstract] [Full Text] [PDF]

				M. A. Febbraio, N. Hiscock, M. Sacchetti, C. P. Fischer, and B. K. Pedersen Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction Diabetes, July 1, 2004; 53(7): 1643 - 1648. [Abstract] [Full Text] [PDF]

				X. Wu, J. Gao, J. Yan, C. Owyang, and Y. Li Hypothalamus-Brain Stem Circuitry Responsible for Vagal Efferent Signaling to the Pancreas Evoked By Hypoglycemia in Rat J Neurophysiol, April 1, 2004; 91(4): 1734 - 1747. [Abstract] [Full Text] [PDF]

				S. N. Cheuvront The Zone Diet Phenomenon: A Closer Look at the Science behind the Claims J. Am. Coll. Nutr., February 1, 2003; 22(1): 9 - 17. [Abstract] [Full Text] [PDF]

				M. A. FEBBRAIO and B. K. PEDERSEN Muscle-derived interleukin-6: mechanisms for activation and possible biological roles FASEB J, September 1, 2002; 16(11): 1335 - 1347. [Abstract] [Full Text] [PDF]

				C. M. Ryan, D. Dulay, C. Suprasongsin, and D. J. Becker Detection of Symptoms by Adolescents and Young Adults With Type 1 Diabetes During Experimental Induction of Mild Hypoglycemia: Role of hormonal and psychological variables Diabetes Care, May 1, 2002; 25(5): 852 - 858. [Abstract] [Full Text] [PDF]

				S. Karlsson, A. J. W. Scheurink, and B. Ahren Gender difference in the glucagon response to glucopenic stress in mice Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R281 - R288. [Abstract] [Full Text] [PDF]

				S. M. Sherck, M. Shiota, J. Saccomando, S. Cardin, E. J. Allen, J. R. Hastings, D. W. Neal, P. E. Williams, and A. D. Cherrington Pancreatic Response to Mild Non-Insulin-Induced Hypoglycemia Does Not Involve Extrinsic Neural Input Diabetes, November 1, 2001; 50(11): 2487 - 2496. [Abstract] [Full Text] [PDF]

				K. Hojlund, M. Wildner-Christensen, O. Eshoj, C. Skjarbak, J. J. Holst, O. Koldkjar, D. Moller Jensen, and H. Beck-Nielsen Reference intervals for glucose, {beta}-cell polypeptides, and counterregulatory factors during prolonged fasting Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E50 - E58. [Abstract] [Full Text] [PDF]

				M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429. [Abstract] [Full Text] [PDF]

				K. Howlett, M. Febbraio, and M. Hargreaves Glucose production during strenuous exercise in humans: role of epinephrine Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1130 - E1135. [Abstract] [Full Text] [PDF]

				F. Fery, L. Plat, P. van de Borne, E. Cogan, and J. Mockel Impaired Counterregulation of Glucose in a Patient with Hypothalamic Sarcoidosis N. Engl. J. Med., March 18, 1999; 340(11): 852 - 856. [Full Text] [PDF]

				K. Zierler Whole body glucose metabolism Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E409 - E426. [Abstract] [Full Text] [PDF]

				P. Genter, N. Berman, M. Jacob, and E. Ipp Counterregulatory hormones oscillate during steady-state hypoglycemia Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E821 - E829. [Abstract] [Full Text] [PDF]

				I. De Glisezinski, I. Harant, F. Crampes, F. Trudeau, A. Felez, J. M. Cottet-Emard, M. Garrigues, and D. Riviere Effect of carbohydrate ingestion on adipose tissue lipolysis during long-lasting exercise in trained men J Appl Physiol, May 1, 1998; 84(5): 1627 - 1632. [Abstract] [Full Text] [PDF]

				P. Del Corral, E. T. Howley, M. Hartsell, M. Ashraf, and M. S. Younger Metabolic effects of low cortisol during exercise in humans J Appl Physiol, March 1, 1998; 84(3): 939 - 947. [Abstract] [Full Text] [PDF]